The Role of THC and CBD in Managing Multiple Sclerosis Spasticity
CBD and THC are two chemicals found in cannabis. When they are used together in a prescription medicine such as nabiximols, they have been studied most in people with multiple sclerosis-related spasticity, which is a type of muscle stiffness, tightness, and involuntary spasms caused by nerve damage. The best evidence is for that specific medical use, not for all kinds of spasms. In research reviews, oral cannabinoids and THC:CBD spray have shown a modest benefit for patient-reported spasticity symptoms, especially in multiple sclerosis. (CNIB)
The reason this combination may help is that the body already has its own cannabinoid system, called the endocannabinoid system. This system helps regulate how nerve cells talk to each other. THC partly activates CB1 and CB2 receptors, which are found mainly at nerve terminals. When these receptors are activated, they can reduce the release of neurotransmitters such as glutamate, which helps calm overactive nerve signaling. In plain terms, the medicine may quiet some of the nerve messages that keep muscles too “switched on.” (Medicines.org.uk)
That calming effect matters because many spasms are driven by the nervous system, not by the muscle itself. In conditions like multiple sclerosis, damaged nerves can send abnormal signals to muscles, making them stiff, tight, or prone to sudden contractions. By reducing excessive signaling in the brain and spinal cord, THC-containing medicines may lower muscle tone and reduce the feeling of stiffness. Animal and human evidence supports this idea, but the effect is usually not dramatic. (Medicines.org.uk)
CBD’s role is less straightforward. CBD does not act like THC in the same direct way, and the exact mechanism for spasm relief is still not fully clear. In combination products, CBD may help balance some of THC’s unwanted effects, and studies suggest it can influence how THC behaves in the body and how strongly its psychoactive effects are felt. That said, the main spasm-relieving action is generally thought to come from THC-driven cannabinoid receptor activity, with CBD acting more as a partner than the main driver. (PMC)
The strongest clinical evidence is for prescribed products like Sativex, which contains THC and CBD in roughly equal amounts and is used in some countries for moderate to severe MS-related spasticity when other treatments have not helped enough. Official product information says it is intended as add-on treatment, and patients are usually assessed during an initial trial to see whether they improve. Reviews also note that the average benefit is modest, and not everyone responds. (Medicines.org.uk)
That modest effect is important. Research found improvements in patient-reported spasticity, but the change was often small, and benefits were not always seen on clinician-measured spasticity scales. In some studies, a meaningful improvement appeared only in a subset of patients, which is why many prescribing rules use a trial period and stop treatment if there is no clear response. (CNIB)
Side effects are a real part of the picture. Common problems include dizziness, drowsiness, fatigue, dry mouth, changes in taste, and thinking or memory issues. Psychiatric effects can also occur, especially in people with a history of psychosis. Because THC can affect alertness and coordination, these medicines may also impair driving or the use of machinery. (MS Trust)
So, CBD and THC together can help some people with spasms because they can dampen overactive nerve signaling through the cannabinoid system. The effect is most established for multiple sclerosis-related spasticity, and even there it is usually partial rather than complete. The combination is best understood as a symptom treatment that may reduce stiffness and spasms in selected patients, not as a universal cure for muscle spasms of every cause. (CNIB)
A few important points add useful context and help keep expectations realistic.
First, the type of spasm matters a lot. The evidence for THC and CBD is mainly for neurological spasticity, especially in conditions like multiple sclerosis. That is different from common muscle cramps after exercise, electrolyte imbalance, or fatigue. Those everyday cramps are usually driven by muscle metabolism or dehydration rather than nerve signaling, so cannabinoids are much less likely to help in a meaningful way.
Another useful detail is how these compounds are used clinically. The best-studied form is not smoked or homemade cannabis, but a standardized medicine called nabiximols (often known as Sativex). It delivers a controlled ratio of THC to CBD, which matters because too much THC increases side effects without necessarily improving spasm control. This highlights a key limitation: results from medical formulations do not always translate to over-the-counter CBD products or recreational cannabis.
It is also worth noting that tolerance can develop over time. The body’s cannabinoid receptors may become less responsive with repeated exposure, which means the effect on spasms can plateau or diminish. This is one reason why some patients report that the benefit feels stronger at the beginning of treatment.
Interactions with other medications are another practical concern. Both THC and CBD can affect liver enzymes that process drugs, meaning they can increase or decrease the levels of other treatments in the body. This is particularly relevant for people already taking medications for neurological conditions, pain, or sleep.
There is also a distinction between subjective relief and objective change. Many studies show that patients feel less stiffness or discomfort, even when measurable muscle tone does not change much. This suggests part of the benefit may come from altered perception of discomfort or improved sleep, not just direct muscle relaxation.
Finally, long-term safety is still being studied. Short-term use is relatively well understood, but questions remain about cognitive effects, dependence risk, and mental health impact with prolonged THC exposure, especially at higher doses.
Taken together, THC and CBD can play a role in managing certain types of spasms, but their usefulness depends heavily on the underlying cause, the formulation used, and individual response.
(Source : ChatGPT)
/image%2F3334645%2F20201111%2Fob_fd07bb_sans-titre-1.jpg)
/image%2F3334645%2F20260506%2Fob_ca3301_image-1-ntmpom.jpg)
/image%2F3334645%2F20251107%2Fob_bb2936_oig1.jpg)